Therma Bright


Therma Bright Inc. is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on transforming innovation into wellness. The company specializes in pain & health management solutions, including devices for circulation, cold sore prevention, and blood clot removal, as well as diagnostic tests for COVID-19. It aims to provide effective, non-invasive, and pain-free healthcare products, leveraging advanced thermal therapy, AI, IoT technologies. The company also develops innovative medical devices such as Benepod for chronic pain relief and PREVA™ for ischemic stroke treatment, and has a strong focus on rapid diagnostic testing, including COVID-19 testing solutions.

Industries

consumer
health-care
personal-health
pharmaceutical

Nr. of Employees

medium (51-250)

Therma Bright


Patents

Devices for applying a topical treatment

US-11865288-B2

View Details

Devices for applying a topical treatment

US-11344707-B2

View Details

Products

Saliva-collected rapid antigen lateral flow test (investigational)

A saliva-collected lateral flow antigen test designed for rapid detection of respiratory viral infection and its variants; investigational use with planned point-of-care and at‑home deployment pending regulatory approvals.

Capillary blood rapid antibody lateral flow test (investigational)

A fingerstick blood lateral flow serology test intended to detect IgG and IgM antibodies with a rapid turnaround for seroprevalence and vaccine response monitoring.

Topical controlled thermal therapy device (dermatological applications)

Handheld device delivering timed, controlled topical thermal and light energy via single-use activators to address early-stage dermatological symptoms and provide topical relief.

Contrast hot/cold neuromodulation device (pain relief)

Device that applies simultaneous controlled hot and cold stimuli to create opposing thermal input for short-term and chronic pain relief, with regulated temperature control and safety firmware.

Inhalation statin formulation program (preclinical)

Preclinical program developing nasal/inhaled statin formulations intended to reduce pulmonary hyperinflammation and viral entry in severe respiratory disease models.

Basket-type clot-retriever device concept (preclinical/dev stage)

Development-stage design for a basket-type clot retriever intended to encapsulate thrombi and reduce distal embolization during mechanical thrombectomy procedures.

View All Products

Services

Development and optimization of lateral flow antigen and antibody assays including reagent selection, cartridge design, saliva collection devices, and prototype production.

IRB/ethics submission support, multisite clinical performance study execution, and data compilation for regulatory submissions.

Coordination with contract manufacturers for component sourcing, injection molding, lateral flow strip production, and assembly to scale production volumes.

Implementation of embedded encrypted tracking and reporting technology to capture test results, product tracking, and validation data while protecting user privacy.

Expertise Areas

  • Point-of-care diagnostic development
  • Lateral flow immunoassay development
  • Clinical performance study design and execution
  • Regulatory submission and EUA/market approval processes
  • Show More (6)

Key Technologies

  • Lateral flow immunoassays
  • Saliva specimen collection workflows
  • Capillary blood serology lateral flow
  • Controlled topical infrared/thermal energy delivery
  • Show More (8)

News & Updates


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.